Delivery Order SPE2DR25D1017-SPE2DR26F8ZKD
- Not listed
- The Defense Logistics Agency awarded a $16,007.47 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 2, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $72,474.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 18, 2025. This non-set-aside competitive award was issued on September 17, 2025, and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to treat high cholesterol and reduce cardiovascular risk in eligible patients....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with a ceiling value of $1,041.42. This competitively awarded, firm fixed-price delivery order was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to treat high cholesterol and reduce...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,214.99 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to lower cholesterol levels and...
- The Defense Logistics Agency awarded a delivery order valued at approximately $65.3K to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. The contract, which became effective on November 11, 2025, with an ultimate completion date of November 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors, valued at $1,041.42. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,157.40 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 23, 2025. This non-competitive delivery order represents a firm fixed-price transaction executed on October 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. REPATHA is a PCSK9 inhibitor prescribed for patients with high cholesterol and...
- The Defense Logistics Agency awarded a delivery order valued at $4,115.11 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors on September 2, 2025, with completion scheduled for September 3, 2025. This firm fixed-price delivery order represents a non-competitive procurement and is being fulfilled by AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to lower cholesterol levels and reduce cardiovascular...
- The Defense Logistics Agency awarded a delivery order valued at $8,826.84 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical product will...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,524.96 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 27, 2025. This competitively awarded, firm fixed-price contract was issued on October 24, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F8ZKDDelivery Order
The Defense Logistics Agency awarded a $17,662.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 12, 2025. This non-competitive delivery order was issued on November 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to treat high cholesterol and reduce cardiovascular risk in eligible patients. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a total contract value of $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and federal healthcare systems worldwide. The company's extensive portfolio of federal medical contracts demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains for the Department of Defense and related federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.7k | 11/10/25 |